Two years after percutaneous coronary intervention, people at risk of a cardiac event had better outcomes with clopidogrel ...

People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open ...

People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open ...

For prolonged antithrombotic treatment after percutaneous coronary intervention (PCI), clopidogrel monotherapy was more ...

Kolkata: The National Pharmaceutical Pricing Authority (NPPA), in an order dated March 27, changed the prices of 80 medicines ...

Three months of dual antiplatelet therapy after PCI may safely balance thrombosis and bleeding risk in both patients with low ...

The following is a summary of "Variations in Antithrombotic Prescriptions and Evaluation of Extended Clopidogrel Therapy ...

A deescalation strategy involving switching from ticagrelor to clopidogrel in patients with acute myocardial infarction (AMI) ...

Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & loss statements.

De-escalating from aspirin plus ticagrelor to aspirin plus clopidogrel 1 month post-percutaneous coronary intervention (PCI) was associated with favorable outcomes in patients with stabilized ...